Study Supports Early Anticoagulant Treatment to Reduce Death in Moderately Ill COVID-19 Patients

Findings from an international multicenter trials showed that while a full dose of heparin didn’t statistically significantly lower incidence of the primary composite of death, mechanical ventilation or ICU admission compared with low-dose heparin, therapeutic heparin did reduce the odds of all-cause death by 78 percent.